Japan’s Takeda Pharmaceutical gave India’s Sun Pharmaceutical and Cipla the rights to commercialize the gastrointestinal drug Vonoprazan in the country.
Tag Archive for: commercialization rights
Roche is returning the global development and commercialization rights to the investigational cancer asset camonsertib to Repare Therapeutics, the Cambridge, Mass. and Montreal-based oncology company announced Monday.